The Clinical Trials Research Unit at the University of Leeds has produced a series of webinars for researchers and clinicians about the UK Myeloma Research Alliance (UKMRA)-Myeloma UK-Concept and Access Research Programme (CARP) and how it supports the development of early phase myeloma clinical trials in the UK.Details
Guidelines on the diagnosis, investigations and initial treatment for myeloma: a British Society for Haematology/UK Myeloma Forum Guideline
These new guidelines, produced by the British Society for Haematology (BSH) and the UK Myeloma Forum, provide healthcare professionals with guidance on the anti-myeloma management of patients with newly diagnosed myeloma.
This important virtual national conference provides an essential update for current and aspiring non medical prescribers on prescribing at the end of life. It is widely recognized that pain and symptom control at the end of life is not always optimal, the development of non medical prescribing has a key role in improving pain and…Details
New treatments for myeloma continue to come through the appraisal pipeline. In the last few months, there have been several new treatment approvals from both the National Institute for Healthcare Excellence (NICE) and the Scottish Medicines Consortium (SMC), which is excellent news for patients. Hopefully, there will be more good news for patients throughout 2021…Details
The latest update to the Blood Cancer Dashboard, a resource developed in collaboration between Janssen and the Blood Cancer Alliance, has been launched. This includes the expansion of the resource to incorporate incidence and mortality data at a national and local level for Scotland, Wales and Northern Ireland, as well as the latest available waiting…Details
University College London has announced the launch of a new National Cancer Research Network observational study (COSMOS) that will recruit patients with MGUS (monoclonal gammopathy of undetermined significance) and smouldering myeloma to help identify the genetic and immunological changes that cause myeloma. This ground-breaking study, which is funded by Cancer Research UK and the Medical…Details
Leeds CTRU launches a series of webinars to introduce the UKMRA-Myeloma UK-Concept and Access Research Programme
The Clinical Trials Research Unit (CTRU) at the University of Leeds is running a series of webinars for researchers and clinicians so they can learn all about the UKMRA-Myeloma UK-Concept and Access Research Programme (CARP) and how it supports the development of early phase myeloma trials. The webinar series will include presentations that will describe…Details
This NICE guideline provides recommendations for non-specialists on assessing and managing low back pain and sciatica. It outlines physical, psychological, pharmacological and surgical treatments to help people manage their low back pain.
Myeloma UK funded research recently published in Leukemia shows that acquisition of new copy number aberrations is associated with relapse and therefore strongly supports the need for repeated molecular analysis at relapse. Chromosomal changes like copy number aberrations (structural amplifications, gains, or deletions) are a feature of myeloma. However, the relationship between copy number aberrations…Details